Dexcom to Present at the William Blair & Company 32nd Annual Growth Stock Conference
SAN DIEGO--(BUSINESS WIRE)--
Dexcom, Inc. (NASDAQ:DXCM) today announced that Terry Gregg, Chief
Executive Officer, will present an update on the company at the William
Blair & Company 32nd Annual Growth Stock Conference in
Chicago on Tuesday, June 12th at 10:50 a.m. (CDT). The
presentation, which will occur live at the Four Seasons Hotel Chicago,
will be concurrently webcast. The link to the webcast will be available
on the Dexcom, Inc. website at www.dexcom.com
under the investor relations, events and webcast section, and will be
archived for future reference.
About Dexcom, Inc.
Dexcom, Inc., headquartered in San Diego, California, is developing and
marketing continuous glucose monitoring systems for ambulatory use by
patients and by healthcare providers in the hospital.
Cautionary Statement Regarding Forward Looking Statements
Dexcom is a medical device company with a limited operating history.
Successful commercialization of the company's products is subject to
numerous risks and uncertainties, including a lack of acceptance in the
marketplace by physicians and patients, the inability to manufacture
products in commercial quantities at an acceptable cost, possible delays
in the company's development programs, the inability of patients to
receive reimbursement from third-party payors and inadequate financial
and other resources. Certain of these risks and uncertainties, in
addition to other risks, are more fully described in the company's
quarterly report on Form 10-Q for the period ending March 31, 2012, as
filed with the Securities and Exchange Commission on May 2, 2012.
Dexcom, Inc.
Steven R. Pacelli
Chief Operating Officer
858-200-0200
Source: Dexcom, Inc.
News Provided by Acquire Media
Close window | Back to top
